Table 1.
Demographics of intent to treat (ITT) study population and baseline VSC concentrations*
| Overall (N = 78) | |
|---|---|
| Sex N (%) | |
| Male | 18 (23.1) |
| Female | 60 (76.9) |
| Race N (%) | |
| American Indian or Alaska Native | 0 |
| Asian | 1 (1.3) |
| Black or African American | 1 (1.3) |
| Native Hawaiian or other Pacific Islander | 0 |
| White | 76 (97.4) |
| Multiple | 0 |
| Age (Years) | 46.3 (12.21) |
| Baseline VSC concentrations (log ppb) | |
| Hydrogen Sulfide | |
| Test - 0.1% w/w o-cymen-5-ol/ 0.6% w/w zinc chloride/ sodium fluoride dentifrice | 2.74 (0.223) |
| Reference - Sodium fluoride dentifrice | 2.70 (0.266) |
| Methyl Mercaptan | |
| Test - 0.1% w/w o-cymen-5-ol/ 0.6% w/w zinc chloride/ sodium fluoride dentifrice | 2.32 (0.275) |
| Reference - Sodium fluoride dentifrice | 2.34 (0.249) |
*
Data are means (SD) or numbers (%).
‘Baseline’ is the sample prior to first treatment on day 1 of each treatment period and is the mean concentration of 3 samples.